Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Ubrogepant
Rimegepant
+6 more
Locations
1
United States
Cleveland Clinic, Main Campus
Cleveland, Ohio, United States
Start Date
April 5, 2024
Primary Completion Date
May 1, 2026
Completion Date
December 1, 2026
Last Updated
October 1, 2025
NCT06789406
NCT04715685
NCT05362292
NCT07193407
NCT07195656
NCT07391306
Lead Sponsor
The Cleveland Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions